Nucletron expands exec ranks

Article

Three new vice presidents have joined the executive ranks of brachytherapy provider Nucletron.

Nucletron expands exec ranks
Three new vice presidents have joined the executive ranks of brachytherapy provider Nucletron. As vice president of global marketing, Jan Boers will be responsible for worldwide marketing and communications, joining the firm after serving in roles at CSM Food, Heinz, and Sara Lee International. John Lapré takes over as Nucletron's vice president of research and development following his most recent stint as VP of research and development for CP Kelco. Bringing nearly 20 years of international experience in the pharmaceutical industry, Dr. Jonathan Briers leads the company’s newly created medical affairs department, having served in product management and medical affairs at Servier International, SmithKline Beecham and, most recently, at Pfizer.  Briers previously held appointments at the University of Manchester Medical School in the U.K. and clinical posts in Manchester and Liverpool. 

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.